SEARCH RESULTS

329930 RESULTS

Merck BACE Inhibitor Clears a Safety Hurdle, Gets New Trial

RESEARCH NEWS 2013-12-19 Research News On December 10, Merck announced  that its BACE inhibitor,  MK-8931, had met initial safety requirements in the Phase 2/3  EPOCH study  of patients with mild to moderate Alzheimer’s disease. Not only will the company proceed with this large t

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE